Download PDF
Semin intervent Radiol 2018; 35(04): 229-237
DOI: 10.1055/s-0038-1669962
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Integrated CT–Fluoroscopy Equipment: Improving the Interventional Radiology Approach and Patient Experience for Treatment of Musculoskeletal Malignancies

Steven Yevich
1   Division of Diagnostic Imaging, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas
,
Bruno C. Odisio
1   Division of Diagnostic Imaging, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas
,
Rahul Sheth
1   Division of Diagnostic Imaging, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas
,
Lambros Tselikas
2   Department of Interventional Radiology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France
,
Thierry de Baère
2   Department of Interventional Radiology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France
,
Frederic Deschamps
2   Department of Interventional Radiology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France
› Author Affiliations
Further Information

Publication History

Publication Date:
05 November 2018 (online)

Also available at
    Permissions and Reprints

Abstract

Integrated CT–fluoroscopy equipment augments the comprehensive approach to the treatment of musculoskeletal (MSK) malignancy by interventional radiology techniques. As the role of minimally invasive treatment expands to meet the highly variable presentation of MSK malignancy, creative solutions to treatment challenges are required to improve locoregional tumor control and durability of pain palliation. Challenges to effective treatment can often be attributed to a combination of aggressive tumor biology, large size, forbidding location, and adverse vascularity. In these cases, a tailored treatment approach may necessitate the application of multiple interventional radiology (IR) techniques that require different image guidance capabilities. Integrated CT–fluoroscopy equipment provides the means to leverage both imaging modalities within the same procedural setting to facilitate the simultaneous application of multiple synergistic treatments and protective measures. This article examines the potential role of hybrid units in the IR treatment of challenging MSK malignancies as a means to empower a paradigm transition for a more comprehensive and patient-tailored approach.

Keywords

integrated - hybrid - musculoskeletal - malignancy - interventional radiology
 

  • References

  • 1 Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006; 12 (20, Pt 2): 6243s-6249s
    CrossrefPubMedGoogle Scholar
  • 2 Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004; 350 (16) 1655-1664
    CrossrefPubMedGoogle Scholar
  • 3 Rizzoli R, Body JJ, Brandi ML. , et al; International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease. Cancer-associated bone disease. Osteoporos Int 2013; 24 (12) 2929-2953
    CrossrefPubMedGoogle Scholar
  • 4 Oster G, Lamerato L, Glass AG. , et al. Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Support Care Cancer 2013; 21 (12) 3279-3286
    CrossrefPubMedGoogle Scholar
  • 5 Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 2007; 110 (08) 1860-1867
    CrossrefPubMedGoogle Scholar
  • 6 Kurup AN, Callstrom MR. Expanding role of percutaneous ablative and consolidative treatments for musculoskeletal tumours. Clin Radiol 2017; 72 (08) 645-656
    CrossrefPubMedGoogle Scholar
  • 7 Ozkan E, Gupta S. Embolization of spinal tumors: vascular anatomy, indications, and technique. Tech Vasc Interv Radiol 2011; 14 (03) 129-140
    CrossrefPubMedGoogle Scholar
  • 8 Rilling WS, Chen GW. Preoperative embolization. Semin Intervent Radiol 2004; 21 (01) 3-9
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Kobayashi K, Ozkan E, Tam A, Ensor J, Wallace MJ, Gupta S. Preoperative embolization of spinal tumors: variables affecting intraoperative blood loss after embolization. Acta Radiol 2012; 53 (08) 935-942
    CrossrefPubMedGoogle Scholar
  • 10 Owen RJ. Embolization of musculoskeletal bone tumors. Semin Intervent Radiol 2010; 27 (02) 111-123
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Chuang VP, Wallace S, Swanson D. , et al. Arterial occlusion in the management of pain from metastatic renal carcinoma. Radiology 1979; 133 (3, Pt 1): 611-614
    CrossrefPubMedGoogle Scholar
  • 12 Forauer AR, Kent E, Cwikiel W, Esper P, Redman B. Selective palliative transcatheter embolization of bony metastases from renal cell carcinoma. Acta Oncol 2007; 46 (07) 1012-1018
    CrossrefPubMedGoogle Scholar
  • 13 Figura N, Smith J, Yu HM. Mechanisms of, and adjuvants for, bone pain. Hematol Oncol Clin North Am 2018; 32 (03) 447-458
    CrossrefPubMedGoogle Scholar
  • 14 Barton PP, Waneck RE, Karnel FJ, Ritschl P, Kramer J, Lechner GL. Embolization of bone metastases. J Vasc Interv Radiol 1996; 7 (01) 81-88
    CrossrefPubMedGoogle Scholar
  • 15 Rossi G, Mavrogenis AF, Rimondi E. , et al. Selective arterial embolisation for bone tumours: experience of 454 cases. Radiol Med (Torino) 2011; 116 (05) 793-808
    CrossrefPubMedGoogle Scholar
  • 16 Ahmed M, Brace CL, Lee Jr FT, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology 2011; 258 (02) 351-369
    CrossrefPubMedGoogle Scholar
  • 17 McMenomy BP, Kurup AN, Johnson GB. , et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol 2013; 24 (02) 207-213
    CrossrefPubMedGoogle Scholar
  • 18 Deschamps F, Farouil G, Ternes N. , et al. Thermal ablation techniques: a curative treatment of bone metastases in selected patients?. Eur Radiol 2014; 24 (08) 1971-1980
    CrossrefPubMedGoogle Scholar
  • 19 Deschamps F, Farouil G, de Baere T. Percutaneous ablation of bone tumors. Diagn Interv Imaging 2014; 95 (7-8): 659-663
    CrossrefPubMedGoogle Scholar
  • 20 Dupuy DE, Liu D, Hartfeil D. , et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer 2010; 116 (04) 989-997
    CrossrefPubMedGoogle Scholar
  • 21 Tomasian A, Wallace A, Northrup B, Hillen TJ, Jennings JW. Spine cryoablation: pain palliation and local tumor control for vertebral metastases. AJNR Am J Neuroradiol 2016; 37 (01) 189-195
    CrossrefPubMedGoogle Scholar
  • 22 Callstrom MR, Charboneau JW, Goetz MP. , et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology 2002; 224 (01) 87-97
    CrossrefPubMedGoogle Scholar
  • 23 Gangi A, Guth S, Imbert JP, Marin H, Dietemann JL. Percutaneous vertebroplasty: indications, technique, and results. Radiographics 2003; 23 (02) e10
    CrossrefPubMedGoogle Scholar
  • 24 Berenson J, Pflugmacher R, Jarzem P. , et al; Cancer Patient Fracture Evaluation (CAFE) Investigators. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncol 2011; 12 (03) 225-235
    CrossrefPubMedGoogle Scholar
  • 25 Ruiz Santiago F, Santiago Chinchilla A, Guzmán Álvarez L, Pérez Abela AL, Castellano García MdelM, Pajares López M. Comparative review of vertebroplasty and kyphoplasty. World J Radiol 2014; 6 (06) 329-343
    CrossrefPubMedGoogle Scholar
  • 26 Filippiadis DK, Marcia S, Masala S, Deschamps F, Kelekis A. Percutaneous vertebroplasty and kyphoplasty: current status, new developments and old controversies. Cardiovasc Intervent Radiol 2017; 40 (12) 1815-1823
    CrossrefPubMedGoogle Scholar
  • 27 Anselmetti GC, Manca A, Ortega C, Grignani G, Debernardi F, Regge D. Treatment of extraspinal painful bone metastases with percutaneous cementoplasty: a prospective study of 50 patients. Cardiovasc Intervent Radiol 2008; 31 (06) 1165-1173
    CrossrefPubMedGoogle Scholar
  • 28 Deschamps F, de Baere T. Cementoplasty of bone metastases. Diagn Interv Imaging 2012; 93 (09) 685-689
    CrossrefPubMedGoogle Scholar
  • 29 Pron G, Holubowich C, Kaulback K. ; Health Quality Ontario. Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: a systematic review. Ont Health Technol Assess Ser 2016; 16 (11) 1-202
    PubMedGoogle Scholar
  • 30 Anselmetti GC. Osteoplasty: percutaneous bone cement injection beyond the spine. Semin Intervent Radiol 2010; 27 (02) 199-208
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Deschamps F, Farouil G, Hakime A, Teriitehau C, Barah A, de Baere T. Percutaneous stabilization of impending pathological fracture of the proximal femur. Cardiovasc Intervent Radiol 2012; 35 (06) 1428-1432
    CrossrefPubMedGoogle Scholar
  • 32 Deschamps F, de Baere T, Hakime A. , et al. Percutaneous osteosynthesis in the pelvis in cancer patients. Eur Radiol 2016; 26 (06) 1631-1639
    CrossrefPubMedGoogle Scholar
  • 33 Cazzato RL, Koch G, Buy X. , et al. Percutaneous image-guided screw fixation of bone lesions in cancer patients: double-centre analysis of outcomes including local evolution of the treated focus. Cardiovasc Intervent Radiol 2016; 39 (10) 1455-1463
    CrossrefPubMedGoogle Scholar
  • 34 Piccioli A, Spinelli MS, Maccauro G. Impending fracture: a difficult diagnosis. Injury 2014; 45 (Suppl. 06) S138-S141
    CrossrefPubMedGoogle Scholar
  • 35 Deschamps F, Farouil G, Hakime A. , et al. Cementoplasty of metastases of the proximal femur: is it a safe palliative option?. J Vasc Interv Radiol 2012; 23 (10) 1311-1316
    CrossrefPubMedGoogle Scholar
  • 36 Calandri M, Yamashita S, Gazzera C. , et al. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival. Eur Radiol 2018; 28 (07) 2727-2734
    CrossrefPubMedGoogle Scholar
  • 37 Tsoumakidou G, Buy X, Garnon J, Enescu J, Gangi A. Percutaneous thermal ablation: how to protect the surrounding organs. Tech Vasc Interv Radiol 2011; 14 (03) 170-176
    CrossrefPubMedGoogle Scholar
  • 38 Buy X, Tok CH, Szwarc D, Bierry G, Gangi A. Thermal protection during percutaneous thermal ablation procedures: interest of carbon dioxide dissection and temperature monitoring. Cardiovasc Intervent Radiol 2009; 32 (03) 529-534
    CrossrefPubMedGoogle Scholar
  • 39 Kurup AN, Schmit GD, Morris JM. , et al. Avoiding complications in bone and soft tissue ablation. Cardiovasc Intervent Radiol 2017; 40 (02) 166-176
    CrossrefPubMedGoogle Scholar
  • 40 Kurup AN, Morris JM, Boon AJ. , et al. Motor evoked potential monitoring during cryoablation of musculoskeletal tumors. J Vasc Interv Radiol 2014; 25 (11) 1657-1664
    CrossrefPubMedGoogle Scholar
  • 41 Tsoumakidou G, Garnon J, Ramamurthy N, Buy X, Gangi A. Interest of electrostimulation of peripheral motor nerves during percutaneous thermal ablation. Cardiovasc Intervent Radiol 2013; 36 (06) 1624-1628
    CrossrefPubMedGoogle Scholar
  • 42 Cornelis FH, Petitpierre F, Fabre T, Gille O, Amoretti N, Hauger O. Percutaneous low-pressure bone stenting to control cement deposition in extensive lytic lesions. Eur Radiol 2017; 27 (09) 3942-3946
    CrossrefPubMedGoogle Scholar
  • 43 Hartung MP, Tutton SM, Hohenwalter EJ, King DM, Neilson JC. Safety and efficacy of minimally invasive acetabular stabilization for preiacetabular metastatic disease with thermal ablation and augmented screw fixation. J Vasc Interv Radiol 2016; 27 (05) 682-688.e1
    CrossrefPubMedGoogle Scholar